ArticleCureus2024

Enhanced Treatment in Severe-Critical COVID-19 With Tocilizumab, Remdesivir, Dexamethasone: A Jordanian Cohort Study.

Abdel-Hameed W Al-Mistarehi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.